Albumin nanoparticles containing the established chemotherapeutic, paclitaxel (marketed under the name Abraxane®), have been approved for the treatment of breast cancer, pancreatic adenocarcinoma and non-small cell lung cancer [84-86]. The gene discussed is ALB; the disease is non-small cell lung carcinoma.